Mydayis is not stronger than Adderall in terms of the drug itself. Both medications contain the exact same active ingredient: mixed amphetamine salts in the same 75:25 ratio of dextroamphetamine to levoamphetamine. The real difference is how long each one works. Mydayis is designed to release medication over a significantly longer window, which means more total amphetamine enters your system over the course of a day, but the peak intensity at any given moment is comparable to Adderall XR at an equivalent dose.
Same Drug, Different Delivery
Mydayis and Adderall (both IR and XR) use identical amphetamine salts. What separates them is the engineering of the capsule. Adderall IR releases everything at once and lasts roughly 4 to 6 hours. Adderall XR uses a double-bead system that pulses medication out in two waves, extending coverage to about 10 to 12 hours. Mydayis takes this a step further with a triple-bead system: one set of beads dissolves immediately, a second set releases when it hits a certain acidity level in the gut (pH 5.5), and a third set releases later at a higher pH (7.0).
This triple-release design means Mydayis can provide symptom control for up to 16 hours on a single capsule. That is the core advantage, and the main reason some people perceive it as “stronger.” It’s not hitting harder; it’s lasting longer. Peak blood levels of amphetamine occur around 8 hours after taking Mydayis in adults, compared to roughly 7 hours for Adderall XR, because the medication is still being released well into the afternoon and evening.
How Dosages Compare
The numbers can be misleading if you compare milligrams side by side. Mydayis comes in doses of 12.5 mg, 25 mg, 37.5 mg, and 50 mg. Adderall XR tops out at 30 mg for most adults. But a higher milligram number on Mydayis doesn’t mean a more intense effect at any single point in the day. That total dose is spread across three release phases rather than two.
Clinical conversion tables illustrate this well. A 37.5 mg dose of Mydayis is approximately equivalent to taking 25 mg of Adderall XR in the morning plus a 12.5 mg immediate-release Adderall booster about 8 hours later. In other words, Mydayis contains more total amphetamine because it needs to cover more hours, not because it’s meant to produce a stronger peak effect.
The maximum recommended dose of Mydayis is 50 mg per day for adults and 25 mg for teens aged 13 to 17. Adderall XR’s maximum is typically 30 mg for adults and 30 mg for children and adolescents. If you’re switching between the two, dosing isn’t a one-to-one swap, and the adjustment depends on how many hours of coverage you need.
Who Each One Is Approved For
One important practical difference: Mydayis is only FDA-approved for patients aged 13 and older. Children 12 and younger end up with higher drug concentrations in their blood at the same dose and experience more side effects, particularly insomnia and appetite loss. Adderall IR and Adderall XR, by contrast, are approved for children as young as 3 (IR) and 6 (XR).
This makes Mydayis primarily a medication for teenagers and adults, especially those who need coverage that stretches into evening hours for homework, late work shifts, or other obligations that extend past the typical Adderall XR window.
Side Effects and the Length Trade-Off
Because the same stimulant is active in your body for more hours, Mydayis carries a higher likelihood of side effects that are tied to duration. Insomnia is the most obvious one. If a medication is still releasing amphetamine 12 to 14 hours after you took it, falling asleep becomes harder, especially if you took your dose after early morning. Appetite suppression can also extend further into the evening, which matters for people who already struggle to eat enough during the day on stimulants.
The core side effect profile is otherwise identical to Adderall’s: dry mouth, increased heart rate, irritability, and potential for weight loss. Neither medication is inherently riskier than the other at properly adjusted doses. The question is really whether you need (and can tolerate) that extra coverage window.
Cost and Generic Availability
Adderall has a major practical advantage here. Generic versions of both Adderall IR and Adderall XR have been available for years, which makes them significantly cheaper with insurance and even without it. Mydayis has had a generic approved as well, but brand-name pricing without insurance runs around $11 per capsule, similar to brand-name Adderall at roughly $12.60 per tablet. The real savings come from whichever version your insurance formulary prefers, and many plans still favor the long-established Adderall generics.
Which One Provides Better Coverage
If your current Adderall XR wears off by mid-afternoon and you find yourself needing a booster dose of immediate-release Adderall to get through the rest of the day, Mydayis was essentially designed for your situation. It rolls that booster into a single morning capsule. For people whose ADHD symptoms primarily affect work or school hours and who don’t need evening coverage, Adderall XR or even Adderall IR may be the better fit, with fewer hours of stimulant-related side effects and lower total daily amphetamine exposure.
The bottom line: Mydayis is longer-acting, not stronger. It delivers more total amphetamine over the day because it covers more hours, but the moment-to-moment effect on focus and attention is comparable to Adderall at an equivalent dose. Choosing between them comes down to how many hours of coverage you actually need.